Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05334732 · ClinicalTrials.gov registry record · NA
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
A NA study of Breast Cancer, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 3
- Study locations
NCT05334732 is a NA study of Breast Cancer that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 250 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05334732, a NA study of Breast Cancer, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
Conditions Studied
Interventions
- BEHAVIORAL SIS TALK Back Intervention
Study Locations (3)
District of Columbia
- Medstar Georgetown University Hospital - Washington D.C.
- MedStar Washington Hospital Center - Washington D.C.
Virginia
- Massey Cancer Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05334732
The ClinicalTrials.gov registry entry for NCT05334732 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which SIS TALK Back Intervention is the first listed.
NCT05334732 reports 3 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Virginia.
Frequently Asked Questions
What is clinical trial NCT05334732 about?
NCT05334732 is a clinical study titled "Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)". The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
What is the current status of trial NCT05334732?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-03-01. Estimated completion is 2026-02-28.
What conditions does trial NCT05334732 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05334732?
The interventions under investigation include: SIS TALK Back Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05334732?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05334732 being conducted?
This trial has 3 study locations across District of Columbia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.